Brief: Invion Ltd Post FY Loss Attributable A$8.8 Million
27/08/2025 02:55
Aug 27 (Reuters) - Invion Ltd IVX.AX: LOSS FOR YEAR ATTRIBUTABLE A$8.8 MILLION Further company coverage: IVX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Invion
See all newsAustralia's Invion rises after securing clinical trial funding arrangements
Brief: Invion Ltd Says Funding Agreements Cover Up To 85% Of Clinical Trials Costs
Brief: Invion Announces Preclinical Research Collaboration With Percheron Therapeutics
Australia's Invion enters ophthalmology agreement with Sangmyung Innovation
Brief: Invion Signs First Ophthalmology Collaboration Agreement With Sangmyung Innovation